Concepedia

David Fiebig

DF

10

Publications

187

Citations

10

H-Index

2016

Active since

Affiliations

Technical University of Darmstadt(Current)

Ferring Pharmaceuticals (Switzerland)

Helmholtz Centre for Infection Research

Merck (Germany)

David Fiebig is an author at Technical University of Darmstadt specializing in immunology, medicine, and antibody engineering.

Top concepts

Publications per year

2016–2022

10

Publications

10

Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture

Jan P. Bogen, Stefania Carrara, David Fiebig et al. · Frontiers in Immunology · 2021 · 30 citations · Full text

, , +19

Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening

Jan P. Bogen, Stefania Carrara, David Fiebig et al. · Frontiers in Immunology · 2020 · 26 citations · Full text

, , +22

Structure of the Dispase Autolysis-inducing Protein from Streptomyces mobaraensis and Glutamine Cross-linking Sites for Transglutaminase

David Fiebig, Stefan Schmelz, Stephan Zindel et al. · Journal of Biological Chemistry · 2016 · 22 citations · Full text

Isolation of Common Light Chain Antibodies from Immunized Chickens Using Yeast Biopanning and Fluorescence‐Activated Cell Sorting

Jan P. Bogen, Juliana Storka, Desislava Yanakieva et al. · Biotechnology Journal · 2020 · 20 citations · Full text

Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System

Stefania Carrara, David Fiebig, Jan P. Bogen et al. · Antibodies · 2021 · 19 citations · Full text

Rows per page

1–5 of 10